Abbott Laboratories (Pakistan) Limited (PSX: ABOT)
Pakistan
· Delayed Price · Currency is PKR
1,265.48
-5.11 (-0.40%)
At close: Jan 29, 2025
PSX: ABOT Revenue
Abbott Laboratories (Pakistan) had revenue of 17.36B PKR in the quarter ending September 30, 2024, with 24.19% growth. This brings the company's revenue in the last twelve months to 63.81B, up 19.21% year-over-year. In the year 2023, Abbott Laboratories (Pakistan) had annual revenue of 55.48B with 12.62% growth.
Revenue (ttm)
63.81B
Revenue Growth
+19.21%
P/S Ratio
1.94
Revenue / Employee
44.63M
Employees
1,430
Market Cap
123.89B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 55.48B | 6.22B | 12.62% |
Dec 31, 2022 | 49.26B | 6.69B | 15.71% |
Dec 31, 2021 | 42.57B | 7.29B | 20.65% |
Dec 31, 2020 | 35.28B | 5.13B | 17.00% |
Dec 31, 2019 | 30.16B | 436.60M | 1.47% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
GlaxoSmithKline Pakistan | 56.23B |
The Searle Company | 28.32B |
AGP Limited | 23.45B |
Highnoon Laboratories | 23.02B |
Shifa International Hospitals | 24.67B |
Citi Pharma | 12.93B |
Ferozsons Laboratories | 15.96B |
Otsuka Pakistan | 3.18B |